|Articles|December 1, 2012

Systemic options for atopic dermatitis continue to present limitations

When weighing use of systemic therapies for severe atopic dermatitis (AD) physicians must consider potential side effects, such as liver and kidney toxicity and myelosuppression, according to Wynnis L. Tom, M.D.


Related to this article

Journal Digest: November 16
Recent dermatology research explores chronic hand eczema prevalence, cancer risk in morphea, pernio, biologic optimization in HS, and melanoma risk prediction.